5The ESRD Incidence Study Group. Divergent trends in the incidence of end-stage renal disease due to type 1 and type 2 diabetes in Europe, Canada and Australia during 1998 - 2002[J]. Diabetir Medicine, 2006,23 ( 2 ) : 1364 - 1369. 被引量：1
6TARGHER G, BERTOLINI L, ZENARI L, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients [ J ]. Diabetic Medicine, 2008, 25 ( 1 ) :45 - 50. 被引量：1
7GUDBJORNSDOTHR S, EEG-OLOFSSON K, CEDERHOLM J,et al. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish national diabetes register (NDR) [ J J. Diabetic Medicine, 2008, 26(1 ):53-60 被引量：1
8REINSCH H, WALTHER T, GROSSE A, et al. Mathematical modeling of regulatory mechanisms in yeast colony development[J].J Tkeor Biol, 2004,229 ( 3 ) :327 - 328. 被引量：1
9SALONEN J T, LAUKKANEN J A, LAUKSONEN D E, et al. Metabolic syndrome and the risk of prostate cancer in Finnishmen: a population-based study[J]. Cancer Epidemiol Biomabers Preview, 2004, 13 ( 10 ) : 1646 - 1650. 被引量：1
10OLALDE J A, MAGARICI M, AMENDOLA F, et al. Clinical outcomes of diabetic foot management with Circulat [ J ]. Phytotherapy Research, 2008, 22 (10) : 1292 - 1298. 被引量：1
